The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,500.00
Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare dise...
December 2022
322 pages
Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 3,500.00
Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY According to the recently published report...
December 2022
52 pages
Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
December 2022
143 pages
Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meni...
December 2022
69 pages
Merkel Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Merkel Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
December 2022
162 pages
Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 3,500.00
Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Metabotropic Glutamate Receptor 4 (GPR...
December 2022
42 pages
Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcar...
December 2022
121 pages
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,500.00
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare dise...
December 2022
1182 pages
Neuroendocrine Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Neuroendocrine Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
December 2022
157 pages
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,500.00
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pip...
December 2022
2271 pages
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,500.00
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
December 2022
1560 pages
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and...
December 2022
82 pages
Pituitary ACTH Hypersecretion (Cushing Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Pituitary ACTH Hypersecretion (Cushing Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and H...
December 2022
37 pages
Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide P...
December 2022
94 pages
Presbyopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Presbyopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pres...
December 2022
68 pages
Prosthetic Joint Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Prosthetic Joint Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pi...
December 2022
54 pages
Recurrent Malignant Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Recurrent Malignant Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pip...
December 2022
45 pages
Retinitis Pigmentosa (Retinitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Retinitis Pigmentosa (Retinitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disea...
December 2022
206 pages
Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 3,500.00
Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update S...
December 2022
46 pages
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 3,500.00
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Survival Motor Neuro...
December 2022
83 pages
Tinea pedis (Athlete Foot) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Tinea pedis (Athlete Foot) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pip...
December 2022
30 pages
Toll Like Receptor 4 (hToll or CD284 or TLR4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 3,500.00
Toll Like Receptor 4 (hToll or CD284 or TLR4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Toll Like Receptor 4 (hToll or CD284 or TLR4) - Toll-...
December 2022
114 pages
Toxoplasmosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Toxoplasmosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide T...
December 2022
44 pages
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmac...
December 2022
44 pages
Western Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Western Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pi...
December 2022
30 pages
Zika Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
US$ 2,000.00
Zika Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
December 2022
216 pages
International Trade in Activated Carbon: Trends and Prospects
US$ 820.00
The reports examine global activated carbon market trends (historical, current and forecast) with respect to international trade including activated carbon global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Alkaloids, Derivs, no Antibiotics, Hormones, in Dosage: Trends and Prospects
US$ 820.00
The reports examine global alkaloids, derivs, no antibiotics, hormones, in dosage market trends (historical, current and forecast) with respect to international trade including alkaloids, derivs, no antibiotics, hormones, in dosage global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Alkaloids, Derivs, Without Antibiotics, Hormones, Bulk: Trends and Prospects
US$ 820.00
The reports examine global alkaloids, derivs, without antibiotics, hormones, bulk market trends (historical, current and forecast) with respect to international trade including alkaloids, derivs, without antibiotics, hormones, bulk global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Antibiotics: Trends and Prospects
US$ 820.00
The reports examine global antibiotics market trends (historical, current and forecast) with respect to international trade including antibiotics global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Antibiotics Nes, Formulated, in Bulk: Trends and Prospects
US$ 820.00
The reports examine global antibiotics nes, formulated, in bulk market trends (historical, current and forecast) with respect to international trade including antibiotics nes, formulated, in bulk global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Antibiotics Nes, in Dosage: Trends and Prospects
US$ 820.00
The reports examine global antibiotics nes, in dosage market trends (historical, current and forecast) with respect to international trade including antibiotics nes, in dosage global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Disinfectants: Trends and Prospects
US$ 820.00
The reports examine global disinfectants market trends (historical, current and forecast) with respect to international trade including disinfectants global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Erythromycin and Its Derivatives: Trends and Prospects
US$ 820.00
The reports examine global erythromycin and its derivatives market trends (historical, current and forecast) with respect to international trade including erythromycin and its derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Glands and Other Organs, Dried, for Therapeutic Uses: Trends and Prospects
US$ 820.00
The reports examine global glands and other organs, dried, for therapeutic uses market trends (historical, current and forecast) with respect to international trade including glands and other organs, dried, for therapeutic uses global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Hormones Nes, Except Contraceptives, in Dosage: Trends and Prospects
US$ 820.00
The reports examine global hormones nes, except contraceptives, in dosage market trends (historical, current and forecast) with respect to international trade including hormones nes, except contraceptives, in dosage global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Hormones Nes, no Antibiotics, Bulk, not Contraceptive: Trends and Prospects
US$ 820.00
The reports examine global hormones nes, no antibiotics, bulk, not contraceptive market trends (historical, current and forecast) with respect to international trade including hormones nes, no antibiotics, bulk, not contraceptive global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Insulin, Formulated, in Bulk: Trends and Prospects
US$ 820.00
The reports examine global insulin, formulated, in bulk market trends (historical, current and forecast) with respect to international trade including insulin, formulated, in bulk global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Insulin, in Dosage: Trends and Prospects
US$ 820.00
The reports examine global insulin, in dosage market trends (historical, current and forecast) with respect to international trade including insulin, in dosage global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Penicillins and Streptomycins, Derivs, in Dosage: Trends and Prospects
US$ 820.00
The reports examine global penicillins and streptomycins, derivs, in dosage market trends (historical, current and forecast) with respect to international trade including penicillins and streptomycins, derivs, in dosage global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Streptomycins and Their Derivatives: Trends and Prospects
US$ 820.00
The reports examine global streptomycins and their derivatives market trends (historical, current and forecast) with respect to international trade including streptomycins and their derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Tetracyclines and Their Derivatives: Trends and Prospects
US$ 820.00
The reports examine global tetracyclines and their derivatives market trends (historical, current and forecast) with respect to international trade including tetracyclines and their derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Tetrahydrocannabinols (all Isomers): Trends and Prospects
US$ 820.00
The reports examine global tetrahydrocannabinols (all isomers) market trends (historical, current and forecast) with respect to international trade including tetrahydrocannabinols (all isomers) global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Vitamin B1 and Its Derivatives: Trends and Prospects
US$ 820.00
The reports examine global vitamin b1 and its derivatives market trends (historical, current and forecast) with respect to international trade including vitamin b1 and its derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Vitamin B12 and Its Derivatives: Trends and Prospects
US$ 820.00
The reports examine global vitamin b12 and its derivatives market trends (historical, current and forecast) with respect to international trade including vitamin b12 and its derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
International Trade in Vitamin B2 and Its Derivatives: Trends and Prospects
US$ 820.00
The reports examine global vitamin b2 and its derivatives market trends (historical, current and forecast) with respect to international trade including vitamin b2 and its derivatives global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
December 2022
90 pages
